Foster Jonathan P.insider trades
In SEC Form 4 filings, Foster Jonathan P. is listed as Chief Financial Officer of Moleculin Biotech, Inc. (MBRX). Foster Jonathan P. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 16.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| MBRXMoleculin Biotech, Inc. | Chief Financial Officer | 5 | Oct 16 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-16
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| MBRXMoleculin Biotech, Inc. | Oct 15 | Oct 16 | M | 130,000 | not reported | not reported | 435,673 | No | Form 4 |
| MBRXMoleculin Biotech, Inc. | Oct 15 | Oct 16 | F | 30,485 | $0.37 | $11,283 | 405,188 | No | Form 4 |
| MBRXMoleculin Biotech, Inc. | Oct 15 | Oct 16 | A · derivative | 260,000 | $0.37 | $96,226 | 1,287,717 | No | Form 4 |
| MBRXMoleculin Biotech, Inc. | Oct 15 | Oct 16 | A · derivative | 260,000 | not reported | not reported | 1,547,717 | No | Form 4 |
| MBRXMoleculin Biotech, Inc. | Oct 15 | Oct 16 | M · derivative | 130,000 | $0.00 | $0 | 1,417,717 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.